Progyny (PGNY) Tops Q4 EPS by 2c

Progyny (NASDAQ: PGNY) reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $214.3 million versus the consensus estimate of $211.78 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Burry doubles down on Nebius short after stock surges 34% on earnings
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c